ID   KOS-002
AC   CVCL_GY90
SY   CSKOS
DR   Wikidata; Q54900338
RX   PubMed=21848623;
RX   PubMed=25190452;
CC   Doubling time: 24.7 hours (PubMed=21848623).
CC   Derived from site: In situ; Bone, left distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Irish Setter; VBO=VBO_0200702.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 8
//
RX   PubMed=21848623; DOI=10.1111/j.1476-5829.2010.00249.x; PMCID=PMC7394284;
RA   Hong S.-H., Osborne T., Ren L., Briggs J.W., Mazcko C., Burkett S.S.,
RA   Khanna C.;
RT   "Protein kinase C regulates ezrin-radixin-moesin phosphorylation in
RT   canine osteosarcoma cells.";
RL   Vet. Comp. Oncol. 9:207-218(2011).
//
RX   PubMed=25190452; DOI=10.1186/s12917-014-0184-9; PMCID=PMC4172958;
RA   Pang L.Y., Argyle S.A., Kamida A., Morrison K.O., Argyle D.J.;
RT   "The long-acting COX-2 inhibitor mavacoxib (Trocoxil TM) has
RT   anti-proliferative and pro-apoptotic effects on canine cancer cell
RT   lines and cancer stem cells in vitro.";
RL   BMC Vet. Res. 10:184.1-184.11(2014).
//